Priothera has announced the appointment of Nigel Clark, PhD, as Chief Business Officer (CBO). Dr. Clark brings over 25 years of experience in commercial and strategic leadership within the biotechnology and pharmaceutical industries.
Company Information
Company
Priothera
Location
Saint-Louis, Grand Est, France
About
Priothera is a late-stage biopharma company pioneering the development of mocravimod, a potential new standard of care in hematologic cancers. The company focuses on adjunctive and maintenance therapy for hematological malignancies, particularly acute myeloid leukemia (AML). They aim to improve patients’ quality of life and outcomes with innovative treatments.
Don't miss Priothera's next move
Get an email the moment Priothera changes its leadership, hires an exec, or expands, usually minutes after it happens.